TMEM165 Polyklonaler Antikörper
TMEM165 Polyklonal Antikörper für WB, IF/ICC, IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 20485-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
20485-1-PBS bindet in WB, IF/ICC, IP, Indirect ELISA TMEM165 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | TMEM165 fusion protein Ag14362 |
| Vollständiger Name | transmembrane protein 165 |
| Berechnetes Molekulargewicht | 324 aa, 35 kDa |
| Beobachtetes Molekulargewicht | 35-40 kDa |
| GenBank-Zugangsnummer | BC003545 |
| Gene symbol | TMEM165 |
| Gene ID (NCBI) | 55858 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Thiopurine methyltransferase or thiopurine S-methyltransferase (TPMT), a member of methyltransferase superfamily, is an enzyme involved in the normal metabolic inactivation of thiopurine drugs such as azathioprine, 6-mercaptopurine and 6-thioguanine. These drugs are generally used as immunosupressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation. Defects in the TPMT gene leads to decreased methylation and decreased inactivation of 6MP leading to enhanced bone marrow toxicity which may cause myelosuppression, anemia, bleeding tendency, leukopenia and infection.











